Higher-Dose Fluvoxamine Fails for COVID Outpatients
(MedPage Today) -- The extensive quest to repurpose a cheap therapy for non-hospitalized COVID patients has once again fallen short, this time using a higher dose of fluvoxamine (Luvox), a selective serotonin reuptake inhibitor (SSRI).
In the...
Source: MedPage Today Infectious Disease - Category: Infectious Diseases Source Type: news
More News: Infectious Diseases